Cargando…
A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention
Percutaneous coronary intervention (PCI) is widely used in clinical treatment of coronary artery disease. However, the effects of PCI on preventing restenosis after revascularization and improving the quality of life were not satisfying. Huxin Formula is formulated by modifying an experienced Chines...
Autores principales: | Wu, Huan-Lin, Wang, Yun-Fei, Li, Jun-Zhe, Zhang, Min-Zhou, Sheng, Xiao-Gang, Wang, Xia, Li, Song, Chen, Qiu-Xiong, Li, Xiao-Qing, Ou, Ai-hua, Ruan, Xin-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058264/ https://www.ncbi.nlm.nih.gov/pubmed/24971144 http://dx.doi.org/10.1155/2014/143064 |
Ejemplares similares
-
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
por: Shi, Lipeng, et al.
Publicado: (2022) -
Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
por: Jiang, Xiao-Min, et al.
Publicado: (2018) -
Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention
por: Zhang, Jun-jie, et al.
Publicado: (2016) -
Nutritional Risk Index Improves the GRACE Score Prediction of Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Ma, Xiao-Teng, et al.
Publicado: (2021) -
Prevalence, predictors, and management for balloon uncrossable or undilatable lesions in patients undergoing percutaneous coronary intervention with in-stent restenosis chronic total occlusion
por: Wang, Yong, et al.
Publicado: (2023)